Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (11)

2024

  1. Analysis of the Evolution of Tuberculosis in Men and Women in Spain Between 2017 and 2022. Is There a Different Incidence Decline by Gender?

    Archivos de Bronconeumologia, Vol. 60, Núm. 5, pp. 312-315

2022

  1. Non-Tuberculous Mycobacterial Diseases in Spain: Treatment and Evolution

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. 457-460

2020

  1. Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on

    Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492

  2. Factors Associated With Extrapulmonary Tuberculosis in Spain and Its Distribution in Immigrant Population

    Open Respiratory Archives, Vol. 2, Núm. 3, pp. 119-126

2016

  1. Factors associated with fatality during the intensive phase of anti-tuberculosis treatment

    PLoS ONE, Vol. 11, Núm. 8

  2. Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment

    Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268

  3. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer

    Journal of Thoracic Oncology, Vol. 11, Núm. 1, pp. 39-51

2013

  1. Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry

    Journal of Asthma, Vol. 50, Núm. 3, pp. 296-301

2012

  1. A predictive scoring instrument for tuberculosis lost to follow-up outcome

    Respiratory Research, Vol. 13

  2. Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches

    Journal of Asthma, Vol. 49, Núm. 4, pp. 416-422

2007

  1. Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME

    Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72